글로벌 장 질환 검사-치료 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 장 질환 검사-치료 시장

Data Bridge Market Research는 장 질환 검사-치료 시장이 2022-2029년 예측 기간에 4.30%의 CAGR로 성장할 것으로 분석했습니다. 주요 시장 참여자들이 의사와 환자가 더 나은 의료 서비스를 받을 수 있도록 돕는 제품 개발에 집중함에 따라 시장은 자본화 측면에서 급속한 확장을 목격할 것으로 예상됩니다.

장 질환은 기생충, 바이러스, 박테리아와 같은 다양한 미생물의 존재로 인해 발생하는 일종의 장 질환입니다. 이러한 미생물은 다양한 식품 및 수역에서 일반적으로 발견되며, 이 질병 범주는 개인 간에도 전염될 수 있습니다. 장 질환 검사 및 치료는 장 질환이 인체에 미치는 영향을 줄이거나 제거하기 위해 시장 참여자가 제공하는 다양한 진단 및 치료 솔루션을 말합니다.

예측 기간 동안 표적 질환을 앓고 있는 환자 수가 증가함에 따라 장 질환 검사-치료 시장 성장이 크게 촉진될 것입니다. 전통적인 방법보다는 첨단 기술을 기반으로 하는 고품질 제품의 가용성도 시장 성장을 촉진하고 있습니다. 나아가 사람들의 생활 수준을 개선하기 위한 정부 개입이 증가하면 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 정부는 주로 이러한 추세를 전통적인 진단 방법에서 첨단 방법으로 전환하는 데 책임이 있습니다.

장 질환 검사 시장은 높은 장비 및 노동 비용과 임상 진단을 위한 정교한 실험실 조건에 대한 의무적 요구 사항으로 인해 어려움을 겪고 있습니다. 이러한 어려움은 효소 결합 면역 흡착 검사(ELISA) 및 중합효소 연쇄 반응(PCR)과 같은 다양한 첨단 저비용 기술의 개발로 인해 앞으로 극복될 것으로 예상됩니다.

This enteric disease testing-treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enteric disease testing-treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Enteric Disease Testing-Treatment Market Scope and Market Size

Enteric disease testing - treatment market is segmented on the basis of disease type, therapeutics, testing technology and end user. Each individual segment’s growth is analysed and these insights are subsequently considered before providing you with the market overview which can help you in understanding and identification of your core applications in the broad market.

• On the basis of disease type, the enteric disease testing - treatment market has been segmented into bacterial enteric diseases, viral enteric diseases and parasitic enteric diseases. Bacterial enteric diseases have been further segmented into C.difficile infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis and shigellosis. Viral enteric diseases have been sub-segmented into rotavirus infection and norovirus infection. Parasitic enteric diseases have segmented into amebiasis, cryptosporidiosis and giardiasis.
• Based on therapeutics, the enteric disease testing - treatment market has been segmented into campylobacter, cryptosporidium, E-Coli, enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), salmonellosis and shigellosis.
• Enteric disease testing-treatment market has been segmented on the basis of testing technology into molecular diagnostics, monoclonal antibodies, immunoassays, differential light scanning, information technology, artificial intelligence (AI), liposomes, flow cytometry, chromatography, diagnostic imaging, gel microdroplets, others
• Based on end user, the enteric disease testing-treatment market has been segmented into hospitals, diagnostic laboratories and physician offices.

Enteric Disease Testing-Treatment Market Country Level Analysis

The enteric disease testing-treatment market is analysed and market size insights and trends are provided by country, disease type, therapeutics, testing technology and end user as referenced above.

The countries covered in the enteric disease testing-treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be the most dominant region for the enteric disease testing-treatment market, with the majority of the population living in urban areas suffering from some form of enteric disease. This population is also migrating to cities, increasing demand for higher-quality healthcare services such as diagnostic products, treatment, and other solutions.

The country section of the enteric disease testing-treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The enteric disease testing-treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteric disease testing-treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteric disease testing-treatment market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Enteric Disease Testing-Treatment Market Share Analysis

The enteric disease testing-treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enteric disease testing-treatment market.

장 질환 검사-치료 시장의 주요 기업으로는 Abbott, BD, Biomerica, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid, CorisBioconcept SPRL, DIASORIN SpA, Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Trinity Biotech Ireland, Thermo Fisher Scientific Inc., Mobidiag Ltd., R-Biopharm, GlaxoSmithKline plc, Bharat Biotech, Sanofi, Janssen Global Services, LLC, Eli Lilly and Company, IDL Biotech AB (publ), Merck & Co., Inc., Novartis AG, Takeda Pharmaceutical Company Limited 등이 있습니다.

SKU-24757